EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy

Yuexiao Tang iD, Tao Yao iD, Xin Tian iD, Xintong Xia iD, Xingxiao Huang iD, Zhewen Qin iD, Zhong Shen iD, Lin Zhao iD, Yaping Zhao iD, Bowen Diao iD, Yan Ping iD, Xiaoxiao Zheng iD und 12 weitere

Journal of Experimental Medicine · 2024

DOI: 10.1084/jem.20231395 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, 2024. Verfasst von Yuexiao Tang und 23 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University Sch…. Hauptthemen laut MEDLINE: Anorexia, Doxorubicin, Endoribonucleases, Growth Differentiation Factor 15. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum-based chemotherapy drugs can lead to the development of anorexia, a detrimental effect on the overall health of cancer patients. However, managing chemotherapy-induced anorexia and subsequent weight loss remains challenging due to limited effective therapeutic strategies. Growth differentiation factor 15 (GDF15) has recently gained significant attention in the context of chemotherapy-induced anorexia. Here, we report that hepatic GDF15 plays a crucial role in regulating body weight in response to chemo drugs cisplatin and doxorubicin. Cisplatin and doxorubicin treatments induce hepatic Gdf15 expression and elevate circulating GDF15 levels, leading to hunger suppression and subsequent weight loss. Mechanistically, selective activation by chemotherapy of hepatic IRE1α-XBP1 pathway of the unfolded protein response (UPR) upregulates Gdf15 expression. Genetic and pharmacological inactivation of IRE1α is sufficient to ameliorate chemotherapy-induced anorexia and body weight loss. These results identify hepatic IRE1α as a molecular driver of GDF15-mediated anorexia and suggest that blocking IRE1α RNase activity offers a therapeutic strategy to alleviate the adverse anorexia effects in chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnorexiaDoxorubicinEndoribonucleasesGrowth Differentiation Factor 15LiverProtein Serine-Threonine KinasesWeight LossX-Box Binding Protein 1AnimalsHumansMiceAntineoplastic AgentsCisplatinMice, Inbred C57BLSignal TransductionUnfolded Protein Response

Substanzen

Antineoplastic AgentsCisplatinDoxorubicinEndoribonucleasesGrowth Differentiation Factor 15Protein Serine-Threonine KinasesX-Box Binding Protein 1ERN1 protein, humanErn1 protein, mouseGDF15 protein, human

Autor:innen und Institutionen

  • Zhejiang Provincial Key Laboratory of Pancreatic Disease, The First Affiliated Hospital, Institute of Translational Medicine, Zhejiang University School of Medicine, Zhejiang University , Hangzhou, China.
  • Key Laboratory of Cancer Prevention and Therapy Combining Traditional Chinese and Western Medicine of Zhejiang Province, Zhejiang Academy of Traditional Chinese Medicine, Tongde Hospital of Zhejiang Province , Hangzhou,…
  • College of Life Sciences, Zhejiang Chinese Medical University , Hangzhou, China.
  • Department of Coloproctology, Hangzhou Third People's Hospital, Hangzhou, China.
  • Division of Life Sciences and Medicine, Department of Endocrinology, Institute of Endocrine and Metabolic Diseases, The First Affiliated Hospital of USTC, Clinical Research Hospital of Chinese Academy of Sciences (Hefei…
  • Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

ORCID-Profile: Yuexiao Tang, Tao Yao, Xin Tian, Xintong Xia, Xingxiao Huang, Zhewen Qin, Zhong Shen, Lin Zhao, Yaping Zhao, Bowen Diao, Yan Ping, Xiaoxiao Zheng, Yonghao Xu, Hui Chen, Tao Qian, Tao Ma, Ben Zhou, Suowen Xu, Qimin Zhou, Yong Liu, Mengle Shao, Wei Chen, Bo Shan, Ying Wu

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Fundamental Research Funds for the Central Universities
  • Natural Science Funding of Zhejiang Province
  • Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents
  • Shanghai Municipal Science and Technology
  • State Administration of Traditional Chinese Medicine
  • Zhejiang Provincial Department of Science and Technology

Zitieren

APA

Tang, Y., Yao, T., Tian, X., Xia, X., Huang, X., Qin, Z., Shen, Z., Zhao, L., Zhao, Y., Diao, B., Ping, Y., Zheng, X., Xu, Y., Chen, H., Qian, T., Ma, T., Zhou, B., Xu, S., Zhou, Q., …, & Wu, Y. (2024). Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy. Journal of Experimental Medicine. https://doi.org/10.1084/jem.20231395

Vancouver

Tang Y, Yao T, Tian X, Xia X, Huang X, Qin Z, et al. Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy. Journal of Experimental Medicine. 2024. doi:10.1084/jem.20231395

BibTeX
@article{Tang2024,
  author = {Tang, Yuexiao and Yao, Tao and Tian, Xin and Xia, Xintong and Huang, Xingxiao and Qin, Zhewen and Shen, Zhong and Zhao, Lin and Zhao, Yaping and Diao, Bowen and Ping, Yan and Zheng, Xiaoxiao and Xu, Yonghao and Chen, Hui and Qian, Tao and Ma, Tao and Zhou, Ben and Xu, Suowen and Zhou, Qimin and Liu, Yong and Shao, Mengle and Chen, Wei and Shan, Bo and Wu, Ying},
  title = {Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy},
  journal = {Journal of Experimental Medicine},
  year = {2024},
  doi = {10.1084/jem.20231395}
}
Kostenlos starten →